相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics
Ying Yu et al.
MOLECULAR NEUROBIOLOGY (2020)
Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189
Natalie M. Guley et al.
EXPERIMENTAL EYE RESEARCH (2019)
Targeting immune cell circuits and trafficking in inflammatory bowel disease
Markus F. Neurath
NATURE IMMUNOLOGY (2019)
Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
Yoo Jin Jung et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury
Jeffrey D. Pressly et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation
Sonia Villapol
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Microglial Activation in Traumatic Brain Injury
Cornelius K. Donat et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
Ping Li et al.
FRONTIERS IN PHARMACOLOGY (2017)
The CB2 receptor and its role as a regulator of inflammation
Caroline Turcotte et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists
Mojgan Aghazadeh Tabrizi et al.
CHEMICAL REVIEWS (2016)
Long-term side effects of glucocorticoids
Merih Oray et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease
Yolanda Gomez-Galvez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist
Wei Bu et al.
FRONTIERS IN NEUROSCIENCE (2016)
Synthesis and biological evaluation of (3′,5′-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist
Chaela S. Presley et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Anti-TNF therapy: past, present and future
Claudia Monaco et al.
INTERNATIONAL IMMUNOLOGY (2015)
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189
Anton Reiner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist
Chaela Presley et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Mesenchymal Stem Cells Induce the Ramification of Microglia Via the Small RhoGTPases Cdc42 and Rac1
Veronika E. Neubrand et al.
GLIA (2014)
CB2 Cannabinoid Receptors as a Therapeutic Target-What Does the Future Hold?
Amey Dhopeshwarkar et al.
MOLECULAR PHARMACOLOGY (2014)
Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists
Servio H. Ramirez et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists
Rachel Ribeiro et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2013)
Microglia: Scapegoat, Saboteur, or Something Else?
Adriano Aguzzi et al.
SCIENCE (2013)
Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention
Alok Kumar et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract
Carlos Sostres et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
Updating the Chemistry and Biology of Cannabinoid CB2 Receptor – Specific Inverse Agonists
Charles A. Lunn
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
Guy A. Cabral et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Pharmacological Characterization of Receptor Redistribution and β-Arrestin Recruitment Assays for the Cannabinoid Receptor 1
Miranda M. C. van der Lee et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Exploring the substituent effects on a novel series of C1′-dimethyl-aryl Δ8-tetrahydrocannabinol analogs
Mathangi Krishnamurthy et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists
C. A. Lunn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration
John C. Ashton et al.
CURRENT NEUROPHARMACOLOGY (2007)
Blood-brain barrier delivery
William M. Pardridge
DRUG DISCOVERY TODAY (2007)
Minocycline for short-term neuroprotection
HF Elewa et al.
PHARMACOTHERAPY (2006)
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
Y Yiangou et al.
BMC NEUROLOGY (2006)
A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo
CA Lunn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Simple, rapid procedure for the synthesis of chloromethyl methyl ether and other chloro alkyl ethers
MA Berliner et al.
JOURNAL OF ORGANIC CHEMISTRY (2005)
Total synthesis of (±)-taiwaniaquinol B via a domino intramolecular Friedel-Crafts acylation/carbonyl α-tert-alkylation reaction
E Fillion et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Inflammation in neurodegenerative disease - A double-edged sword
T Wyss-Coray et al.
NEURON (2002)
分享论文
